Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Gains from Investment Securities (2024 - 2025)

Historic Gains from Investment Securities for Camp4 Therapeutics (CAMP) over the last 2 years, with Q3 2025 value amounting to -$197000.0.

  • Camp4 Therapeutics' Gains from Investment Securities fell 10947.81% to -$197000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $189000.0, marking a year-over-year decrease of 9090.68%. This contributed to the annual value of $364000.0 for FY2024, which is 7394.42% down from last year.
  • Camp4 Therapeutics' Gains from Investment Securities amounted to -$197000.0 in Q3 2025, which was down 10947.81% from $220000.0 recorded in Q2 2025.
  • Camp4 Therapeutics' Gains from Investment Securities' 5-year high stood at $2.1 million during Q3 2024, with a 5-year trough of -$197000.0 in Q3 2025.